Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks
source: Haematologica
year: 2017
authors: Rafii H, Bernaudin F, Rouard H, Vanneaux V, Ruggeri A, Cavazzana M, Gauthereau V, Stanislas A, Benkerrou M, De Montalembert M, Ferry C, Girot R, Arnaud C, Kamdem A, Gour J, Touboul C, Cras A, Kuentz M, Rieux C, Volt F, Cappelli B, Maio KT, Paviglianiti A, Kenzey C, Larghero J, Gluckman E
summary/abstract:Efforts to implement family cord blood banking have been developed in the past decades for siblings requiring stem cell transplantation for conditions such as sickle cell disease. However, public banks are faced with challenging decisions about the units to be stored, discarded, or used for other endeavors. We report here 20 years of experience in family cord blood banking for sickle cell disease in two dedicated public banks. Participants were pregnant women who had a previous child diagnosed with homozygous sickle cell disease. Participation was voluntary and free of charge. All mothers underwent mandatory serological screening. Cord blood units were collected in different hospitals, but processed and stored in two public banks. A total of 338 units were stored for 302 families. Median recipient age was six years (11 months-15 years). Median collected volume and total nucleated cell count were 91 mL (range 23-230) and 8.6×108 (range 0.7-75×108), respectively. Microbial contamination was observed in 3.5% (n=12), positive hepatitis B serology in 25% (n=84), and homozygous sickle cell disease in 11% (n=37) of the collections. Forty-four units were HLA-identical to the intended recipient, and 28 units were released for transplantation either alone (n=23) or in combination with the bone marrow from the same donor (n=5), reflecting a utilization rate of 8%. Engraftment rate was 96% with 100% survival. Family cord blood banking yields good quality units for sibling transplantation. More comprehensive banking based on close collaboration among banks, clinical and transplant teams is recommended to optimize the use of these units.
organization: Assistance Publique-Hôpitaux de Paris; Centre Scientifique de Monaco; Centre Hospitalier Intercommunal, Paris XII University, Créteil; EFS Ile de France; Sorbonne Paris Cité, INSERM,France; Necker Children's Hospital,France; Groupe Hospitalier Universitaire Ouest,France; Robert Debré Hospital, FranceDOI: 10.3324/haematol.2016.163055
read more full text
Related Content
-
Sickle Beta Zero Thalassemia DiseaseSickle Beta Zero Thalassemia (Sickle BA-...
-
Study Suggests Ways of Improving Newborn Screening for Sickle Cell DiseaseResearchers in Spain have defined cutoff...
-
Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical TrialBackground: Sickle cell anemia (SCA), ...
-
5 Facts You Should Know About Sickle Cell Diseasehttps://www.onescdvoice.com/wp-content/u...
-
MARAC Advisory Statement: COVID-19 UpdateAugust 26, 2021 — The Sickle Cell Dise...
-
Meet the oneSCDvoice community!https://www.onescdvoice.com/wp-content/u...
-
New digital education platform for the SCD communityhttps://www.onescdvoice.com/wp-content/u...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.